Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VEDOLIZUMAB Cause Rheumatoid factor positive? 304 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Rheumatoid factor positive have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.4% of all adverse event reports for VEDOLIZUMAB.

304
Reports of Rheumatoid factor positive with VEDOLIZUMAB
0.4%
of all VEDOLIZUMAB reports
290
Deaths
248
Hospitalizations

How Dangerous Is Rheumatoid factor positive From VEDOLIZUMAB?

Of the 304 reports, 290 (95.4%) resulted in death, 248 (81.6%) required hospitalization, and 247 (81.3%) were considered life-threatening.

Is Rheumatoid factor positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 304 reports have been filed with the FAERS database.

What Other Side Effects Does VEDOLIZUMAB Cause?

Off label use (21,017) Colitis ulcerative (13,455) Crohn's disease (9,759) Drug ineffective (8,424) Diarrhoea (7,493) Abdominal pain (6,401) Fatigue (5,477) Haematochezia (5,215) Frequent bowel movements (4,527) Arthralgia (4,028)

What Other Drugs Cause Rheumatoid factor positive?

METHOTREXATE (4,237) TOCILIZUMAB (4,065) ABATACEPT (4,041) ADALIMUMAB (4,020) LEFLUNOMIDE (3,865) RITUXIMAB (3,793) HYDROXYCHLOROQUINE (3,791) INFLIXIMAB (3,584) ETANERCEPT (3,568) SULFASALAZINE (3,306)

Which VEDOLIZUMAB Alternatives Have Lower Rheumatoid factor positive Risk?

VEDOLIZUMAB vs VELAGLUCERASE ALFA VEDOLIZUMAB vs VELCADE VEDOLIZUMAB vs VELETRI VEDOLIZUMAB vs VELIPARIB VEDOLIZUMAB vs VEMURAFENIB

Related Pages

VEDOLIZUMAB Full Profile All Rheumatoid factor positive Reports All Drugs Causing Rheumatoid factor positive VEDOLIZUMAB Demographics